About the Bietti'S Crystalline Dystrophy Session
Bietti's Crystalline Dystrophy is a rare genetic disorder affecting the eyes, characterized by the accumulation of small, yellow-white crystals in the retina and the degeneration of the choroid. Typically diagnosed in early adulthood, it initially manifests as night blindness and gradually progresses to peripheral vision loss. The condition is caused by mutations in the CYP4V2 gene, which disrupts lipid metabolism in the retina. Diagnosis involves detailed ophthalmic examinations such as fundus photography and optical coherence tomography (OCT) to detect the characteristic retinal changes and crystals.
Currently, treatment options are limited, focusing on managing symptoms and slowing disease progression through regular monitoring and lifestyle adjustments. Genetic counseling is essential for affected individuals and their families due to the condition's autosomal recessive inheritance pattern. Ongoing research aims to identify therapeutic strategies targeting lipid metabolism abnormalities to potentially improve outcomes for patients with Bietti's Crystalline Dystrophy.
Topics Covered in Bietti'S Crystalline Dystrophy
CYP4V2 Mutations
Retinal Crystalline Deposits
Corneal Limbal Crystals
RPE & Choriocapillaris Atrophy
Lipid Metabolism Defects
Gene Augmentation Therapy
Related Scientific Sessions at IOC 2027
Why Attend the Bietti'S Crystalline Dystrophy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Bietti'S Crystalline Dystrophy work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Bietti'S Crystalline Dystrophy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Bietti'S Crystalline Dystrophy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Bietti'S Crystalline Dystrophy Conference 2027 — FAQs
What is the Bietti'S Crystalline Dystrophy track at IOC 2027?
The Bietti'S Crystalline Dystrophy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Bietti'S Crystalline Dystrophy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Bietti'S Crystalline Dystrophy sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Bietti'S Crystalline Dystrophy are all welcome — whether presenting or attending.
Can I present my research in the Bietti'S Crystalline Dystrophy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Bietti'S Crystalline Dystrophy sessions?
Yes. IOC 2027 is a hybrid conference — attend the Bietti'S Crystalline Dystrophy track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.